TELA Bio Inc
TELA1.900USD
+0.040+2.15%
交易中 （美东）报价延迟15分钟
75.15M总市值
亏损市盈率 TTM
关于 TELA Bio Inc 公司
TELA Bio, Inc. 是一家商业阶段的医疗技术公司。该公司专注于提供软组织重建解决方案，通过优先保护和恢复患者自身的解剖结构来优化临床结果。其首批产品组合 OviTex 增强组织基质 (OviTex) 解决了疝气修复和腹壁重建方面尚未满足的需求。其 OviTex 产品组合包括多种产品配置，旨在解决疝气修复和腹壁重建中的各种外科手术，包括腹股沟疝、腹股沟疝和食管裂孔疝修复。该公司的 OviTex 产品包括 OviTex 1S、OviTex 2S 和 OviTex LPR。其第二批产品组合 OviTex PRS 增强组织基质 (OviTex PRS) 解决了整形和重建外科方面尚未满足的需求。OviTex PRS 适用于植入，以加强需要软组织修复的患者中存在的软组织薄弱处。
公司简介
公司代码TELA
公司名称TELA Bio Inc
上市日期Nov 08, 2019
CEOMr. Antony Koblish
员工数量209
证券类型Ordinary Share
年结日Nov 08
公司地址1 Great Valley Parkway, Suite 24
城市MALVERN
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编19355
电话14843202930
网址https://www.telabio.com/
公司代码TELA
上市日期Nov 08, 2019
CEOMr. Antony Koblish
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Ms. Lisa N. Colleran
Ms. Lisa N. Colleran
Independent Director
Independent Director
14.22K
+126.79%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+126.79%
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Roberto E. Cuca, J.D.
Mr. Roberto E. Cuca, J.D.
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Ms. Lisa N. Colleran
Ms. Lisa N. Colleran
Independent Director
Independent Director
14.22K
+126.79%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
业务USD
名称
营收
占比
OviTex
12.11M
65.38%
OviTex PRS
6.04M
32.63%
Other
367.00K
1.98%
暂无数据
业务
地区
业务USD
名称
营收
占比
OviTex
12.11M
65.38%
OviTex PRS
6.04M
32.63%
Other
367.00K
1.98%
股东统计
更新时间: 7月31日 周四
更新时间: 7月31日 周四
持股股东
股东类型
持股股东
持股股东
占比
Nantahala Capital Management, LLC
12.92%
EW Healthcare Partners
10.39%
North Run Capital, LP
9.31%
SilverArc Capital Management, LLC
7.01%
Lytton (Laurence W)
6.20%
Other
54.17%
持股股东
持股股东
占比
Nantahala Capital Management, LLC
12.92%
EW Healthcare Partners
10.39%
North Run Capital, LP
9.31%
SilverArc Capital Management, LLC
7.01%
Lytton (Laurence W)
6.20%
Other
54.17%
股东类型
持股股东
占比
Hedge Fund
41.50%
Investment Advisor
11.37%
Venture Capital
10.42%
Investment Advisor/Hedge Fund
10.10%
Individual Investor
8.40%
Research Firm
2.33%
Other
15.89%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
184
33.43M
84.52%
-6.77M
2025Q1
191
33.22M
84.09%
-7.97M
2024Q4
187
31.75M
80.76%
+976.11K
2024Q3
178
22.55M
84.95%
-6.37M
2024Q2
170
20.61M
83.03%
-5.54M
2024Q1
157
22.19M
89.70%
-5.95M
2023Q4
151
21.96M
89.44%
-4.89M
2023Q3
146
22.32M
90.91%
-4.91M
2023Q2
142
22.34M
91.32%
+1.25M
2023Q1
130
16.96M
88.34%
-4.55M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Nantahala Capital Management, LLC
5.11M
12.92%
+1.23M
+31.81%
Apr 30, 2025
EW Healthcare Partners
4.11M
10.39%
--
--
Mar 31, 2025
North Run Capital, LP
3.68M
9.31%
+1.70M
+85.75%
Mar 31, 2025
SilverArc Capital Management, LLC
2.77M
7.01%
-294.36K
-9.60%
Mar 31, 2025
Lytton (Laurence W)
2.45M
6.2%
+1.11M
+83.00%
Sep 30, 2024
Stonepine Capital Management, LLC
2.06M
5.2%
-297.87K
-12.66%
Mar 31, 2025
The Vanguard Group, Inc.
1.93M
4.87%
+52.59K
+2.80%
Mar 31, 2025
Dafna Capital Management, LLC
1.44M
3.64%
--
--
Mar 31, 2025
Grow Funds LLC
1.40M
3.54%
+1.40M
--
Jul 24, 2024
Pentwater Capital Management LP
998.75K
2.52%
-1.25K
-0.12%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
占比0.01%
ProShares Hedge Replication ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
iShares Russell 2000 ETF
占比0%
Global X Russell 2000 ETF
占比0%
Global X Russell 2000 Covered Call ETF
占比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0%
ProShares UltraPro Russell2000
占比0%
Proshares Ultra Russell 2000
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
